当前位置:
X-MOL 学术
›
Haematologica
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience.
Haematologica ( IF 8.2 ) Pub Date : 2024-10-31 , DOI: 10.3324/haematol.2024.286332 Marika Porrazzo,Tiziana Moscato,Giuseppe Sapienza,Fabrizio Accardi,Caterina Patti,Clotilde Cangialosi,Carmelo Costanza,Roberto Bono,Stefania Tringali,Cristina Rotolo,Emilia Gigliotta,Andrea Rizzuto,Manuela Giuseppa Ingrascè,Giulia Butera,Laura Di Noto,Alessandra Santoro,Anna Marfia,Cirino Botta,Sergio Siragusa,Massimo Martino,Luca Castagna
Haematologica ( IF 8.2 ) Pub Date : 2024-10-31 , DOI: 10.3324/haematol.2024.286332 Marika Porrazzo,Tiziana Moscato,Giuseppe Sapienza,Fabrizio Accardi,Caterina Patti,Clotilde Cangialosi,Carmelo Costanza,Roberto Bono,Stefania Tringali,Cristina Rotolo,Emilia Gigliotta,Andrea Rizzuto,Manuela Giuseppa Ingrascè,Giulia Butera,Laura Di Noto,Alessandra Santoro,Anna Marfia,Cirino Botta,Sergio Siragusa,Massimo Martino,Luca Castagna
Not available.
中文翻译:
daratumumab/硼替佐米/沙利度胺和地塞米松诱导治疗对符合移植条件的新诊断多发性骨髓瘤中免化疗干细胞动员的影响:多中心真实世界经验。
不可用。
更新日期:2024-10-31
中文翻译:
daratumumab/硼替佐米/沙利度胺和地塞米松诱导治疗对符合移植条件的新诊断多发性骨髓瘤中免化疗干细胞动员的影响:多中心真实世界经验。
不可用。